5967 |
The Future of BRS: Insights From the COMPARE-ABSORB Trial |
Pieter Smits |
Apr. 19. 24 |
5966 |
Novel Drug-Eluting Stent Designs: Not Yet Plateau, Still Need to Go!!! |
David Joel Cohen |
Apr. 19. 24 |
5965 |
DAPT Duration in Complex PCI: Unsettled or Already Established Issues? |
Duk-Woo Park |
Apr. 19. 24 |
5964 |
Long-Term Antiplatelet Management Beyond 1-Year Post-ACS or Post-PCI |
Hyo-Soo Kim |
Apr. 19. 24 |
5963 |
When to Escalate or De-Escalate in ACS/PCI |
Tullio Palmerini |
Apr. 19. 24 |
5962 |
Contemporary Best Antiplatelet Strategy in HBR or CHIP Patients: How and What? |
David Joel Cohen |
Apr. 19. 24 |
5961 |
How I Use Angio-Based Physiology to Guide My Case in the Cath Lab: Practical Appraisal |
William F. Fearon |
Apr. 19. 24 |
5960 |
The Fate of Deferred Lesions; Insight From the IRIS-FFR Registry |
Jung-Min Ahn |
Apr. 19. 24 |
5959 |
Step-by-Step Physiological Assessment to Accomplish Physiology Guide PCI |
Hitoshi Matsuo |
Apr. 19. 24 |
5958 |
The Series of FAME Studies: A Paradigm Shift in Our Thinking About Interventional Cardiology |
William F. Fearon |
Apr. 19. 24 |